Troy Trygstad, PharmD, PhD, MBA, Pharmacy Times Editor in Chief

Over the past decade, physician employment has skyrocketed, with small-business primary care clinics being gobbled up at staggering rates by large corporations.

Generic drug products are an essential component to our health care system.

Prescriber and pharmacist attitudes toward patient adherence can be an important factor in the patient–provider relationship.

Should a person who is not exposed to education about the dangers of CNS-active medications and driving be thought of as irresponsible?

Third-party payers in the pharmacy arena came along in the 1970s as a means by which a patient’s medications could be covered.

At more than 260 million users strong, nearly 9 of every 10 Americans use OTC medications on a regular basis.

I’ve written a number of articles over the past few months and years about the unstoppable, unwavering, and now accelerating march toward value-driven care and payment reform.

For more than a half-century now, we’ve been debating who should pay for health care: patients, consumers, employers, taxpayers, or charities?

Pharmacy benefit managers play an important and necessary role within our private system of health care.

Lifelock is an identity protection firm that promotes itself as being able to reduce the risk of identity theft or fix it after it occurs.

It was with great fanfare that Amazon announced early last month that it had made its first drone delivery from its Cambridge, England, facility. I thought it interesting that the Wall Street Journal’s article about the launch of the service used medication delivery as an exemplar to highlight the advantages of drone delivery not once, but twice.

It’s now been just over a month since the completion of one of the more unforeseen elections cycles in the history of the United States. For political junkies, the exit polls and final vote tallies provided a number of insights about the mood of America.

The Advisory Board Company is a research, technology, and consulting firm with longstanding and deep relationships in Washington, DC.

It’s an exciting time for the profession of pharmacy, with diversity of opportunity continuing to grow dramatically as our health care system redesigns itself, slowly but surely moving from a system engineered for “sick care” encounters and mechanical throughput to one oriented toward health improvement and outcomes-based value.

It seems that just about every month now, there is another public outcry in response to a new innovator product that is priced well above convention or to a dramatic price hike for a product that has been in the marketplace for years.

For the past decade, health economists and policy makers have frequently espoused the following axiom: bending the cost curve will enable a sustainable health care system.

For those watching the generics marketplace over the past few years, the industry has been anything but boring or conventional.

For more than 3 decades now, pharmacy has been talking the talk but has struggled to walk the walk.

We can do more than act as dispensing police and check in with our state Prescription Drug Monitoring System; we can play an active role in preventing and treating this disease called drug addiction.

The magnitude of the benefit of OTC medications to the health care system is often underappreciated.

The term bellwether comes from an ageold practice in sheepherding of putting a bell on the sheep that leads the flock.

Groupthink can lead to decisions and actions within, and by, a group that are curious, seemingly disconnected, and often misunderstood from the perspective of stakeholders outside the group.